Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Salaroglio IC, Belisario DC, Akman M, La Vecchia S, Godel M, Anobile DP, Ortone G, Digiovanni S, Fontana S, Costamagna C, Rubinstein M, Kopecka J, Riganti C.
Salaroglio IC, et al.
J Exp Clin Cancer Res. 2022 Aug 11;41(1):243. doi: 10.1186/s13046-022-02447-6.
J Exp Clin Cancer Res. 2022.
PMID: 35953814
Free PMC article.